Varda Space, an in-space pharmaceutical manufacturing startup, raised $250 million in Series D funding at a $1.6 billion valuation. The company operates uncrewed orbital capsules to produce drugs in microgravity and plans to launch two capsules simultaneously on Thursday. With 28 launches booked through 2027-2029, Varda expects pharmaceutical revenue to become its primary business by 2032.